Andreas Halvorsen - Viking Global Investors
Holding/activity history for Immunovant, Inc. (IMVT)
← All IMVT superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2025 Q2 | 0 | 0.00 | Sell 100.00% | 0.06 | $12.72–17.15 · VW $15.14i | SEC | |
| 2025 Q1 | 1,114,827 | 0.06 | Reduce 20.78% | 0.02 | $14.16–25.61 · VW $19.88i | $19,052,393 | SEC |
| 2024 Q4 | 1,407,290 | 0.11 | Reduce 39.36% | 0.09 | $23.88–32.10 · VW $27.85i | $34,858,573 | SEC |
| 2024 Q3 | 2,320,902 | 0.24 | $28.51 | $66,168,916 | SEC | ||
| 2024 Q2 | 2,320,902 | 0.24 | Add 28.29% | 0.05 | $24.67–32.40 · VW $28.10i | $61,271,813 | SEC |
| 2024 Q1 | 1,809,172 | 0.22 | Buy | 0.22 | $29.71–45.58 · VW $36.74i | $58,454,347 | SEC |
Price snapshot:
Current price$38.70
52-week low$14.32
52-week high$41.23